{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:15:33Z","timestamp":1789676133277,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.neuropharm.2008.06.004","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T09:26:52Z","timestamp":1213176412000},"page":"190-197","source":"Crossref","is-referenced-by-count":143,"title":["The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator"],"prefix":"10.1016","volume":"56","author":[{"given":"Janet L.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.06.004_bib1","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.94.20.11031","article-title":"The interaction of the general anesthetic etomidate with the \u03b3-aminobutyric acid type A receptor is influenced by a single amino acid","volume":"94","author":"Belelli","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/2661","article-title":"Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy","volume":"4","author":"Brooks-Kayal","year":"1998","journal-title":"Nature Med."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1471-4159.2000.740827.x","article-title":"Identification of an amino acid defining the distinct properties of murine \u03b21 and \u03b23 subunit-containing GABAA receptors","volume":"74","author":"Cestari","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0022-1759(96)00032-4","article-title":"Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody","volume":"193","author":"Chesnut","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nurt.2006.10.001","article-title":"Stiripentol","volume":"4","author":"Chiron","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib6","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of \u03b13-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/jpet.106.104844","article-title":"Identification of structures with GABAA receptor \u03b1 subunits that regulate the agonist action of pentobarbital","volume":"318","author":"Drafts","year":"2006","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/mcne.2002.1143","article-title":"A lysine residue in the \u03b23 subunit contributes to the regulation of GABAA receptor activity by voltage","volume":"20","author":"Fisher","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuron.2007.11.002","article-title":"Activation of GABAA receptors: views from outside the synaptic cleft","volume":"56","author":"Glykys","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on the GABAA receptors are mediated by the \u03b2 subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjp.0700927","article-title":"Subunit-dependent interaction of the general anaesthetic etomidate with the \u03b3-aminobutyric acid type A receptor","volume":"120","author":"Hill-Venning","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABAA receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","article-title":"Drug interactions at GABAA receptors","volume":"67","author":"Korpi","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2005.05.009","article-title":"GABAA receptor subtypes as targets for neuropsychiatric drug development","volume":"109","author":"Korpi","year":"2006","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib17","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1523\/JNEUROSCI.12-11-04151.1992","article-title":"The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development","volume":"12","author":"Laurie","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib18","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/brain\/awl287","article-title":"Altered expression of \u03b13-containing GABAA receptors in the neocortex of patients with focal epilepsy","volume":"129","author":"Loup","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.bjp.0701721","article-title":"SB-205384: a GABAA receptor modulator with novel mechanism of action that shows subunit selectivity","volume":"123","author":"Meadows","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/mol.65.5.1191","article-title":"Selective antagonism of 5\u03b1-reduced neurosteroid effects at GABAA receptors","volume":"65","author":"Mennerick","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/mol.55.1.168","article-title":"Spontaneous and \u03b3-aminobutyric acid (GABA)-activated GABAA receptor channels formed by \u025b subunit-containing isoforms","volume":"55","author":"Neelands","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1261\/rna.349107","article-title":"Editing modifies the GABAA receptor subunit \u03b13","volume":"13","author":"Ohlson","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib25","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1523\/JNEUROSCI.2877-04.2004","article-title":"Altered expression of the \u03b4 subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy","volume":"24","author":"Peng","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2007.06.050","article-title":"Effect of the \u03b1 subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptors","volume":"1165","author":"Picton","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib27","first-page":"199","article-title":"A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study","volume":"34","author":"Poisson","year":"1984","journal-title":"Arnzeimittel-forschung"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib28","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1523\/JNEUROSCI.19-11-04654.1999","article-title":"Differential expression of \u03b11, \u03b12, \u03b13, and \u03b15 GABAA receptor subunits in seizure-prone and seizure-resistant rat models of temporal lobe epilepsy","volume":"19","author":"Poulter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1113\/jphysiol.2006.113134","article-title":"Downregulation of tonic GABA currents following epileptogenic stimulation of rat hippocampal cultures","volume":"577","author":"Qi","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1528-1167.2006.00497.x","article-title":"Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABAA-receptor channels","volume":"47","author":"Quilichini","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-6-1","article-title":"Impact of \u025b and \u03b8 subunits on pharmacological properties of \u03b13\u03b21 GABAA receptors expressed in Xenopus oocytes","volume":"6","author":"Ranna","year":"2006","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2004.11.002","article-title":"Transmembrane residues define the action of isoflurane at the GABAA receptor alpha-3 subunit","volume":"1032","author":"Schofield","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0920-1211(92)90088-B","article-title":"Comparative anticonvulsant potency and pharmacokinetics of (+)- and (-)-enantiomers of stiripentol","volume":"12","author":"Shen","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/jpet.104.070342","article-title":"Compounds exhibiting selective efficacy for different \u03b2 subunits of human recombinant \u03b3-aminobutyric acidA receptors","volume":"311","author":"Smith","year":"2004","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/978-1-4757-6376-8_7","article-title":"GABA and its receptors in epilepsy","volume":"548","author":"Sperk","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.1996.tb15221.x","article-title":"Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination","volume":"117","author":"Thompson","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib37","first-page":"154","article-title":"Stiripentol. A novel antiepileptic drug","volume":"57","author":"Trojnar","year":"2005","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0896-6273(94)90330-1","article-title":"A novel allosteric modulatory site on the GABAA receptor \u03b2 subunit","volume":"12","author":"Wafford","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.06.004_bib39","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the \u03b3-aminobutyric acid type A receptor is determined by a single amino acid in the \u03b22 and \u03b23 subunit","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution of thirteen GABAA receptor subunits mRNAs in the rat brain. I. Telencephalon, diencephalons, mesencephalon","volume":"12","author":"Wisden","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib41","doi-asserted-by":"crossref","first-page":"17154","DOI":"10.1073\/pnas.0508752102","article-title":"A schizophrenia-related sensorimotor deficit links \u03b13-containing GABAA receptors to a dopamine hyperfunction","volume":"102","author":"Yee","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.004_bib42","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1523\/JNEUROSCI.1555-07.2007","article-title":"Altered localization of GABAA receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080800186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080800186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T02:17:33Z","timestamp":1557627453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839080800186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S002839080800186X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}